Clear Harbor Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $670K | Sell |
4,273
-89
| -2% | -$13.3K | 0.04% | 277 |
|
|
2026
Q1 | $666K | Sell |
4,362
-66
| -1% | -$10.1K | 0.05% | 273 |
|
|
2025
Q4 | $610K | Hold |
4,428
| – | – | 0.04% | 277 |
|
|
2025
Q3 | $568K | Sell |
4,428
-310
| -7% | -$37.8K | 0.04% | 271 |
|
|
2025
Q2 | $573K | Buy |
4,738
+245
| +5% | +$27.6K | 0.04% | 252 |
|
|
2025
Q1 | $501K | Hold |
4,493
| – | – | 0.04% | 262 |
|
|
2024
Q4 | $437K | Buy |
4,493
+70
| +2% | +$7.46K | 0.03% | 256 |
|
|
2024
Q3 | $509K | Buy |
4,423
+100
| +2% | +$11.3K | 0.04% | 235 |
|
|
2024
Q2 | $460K | Hold |
4,323
| – | – | 0.04% | 233 |
|
|
2024
Q1 | $418K | Sell |
4,323
-949
| -18% | -$97.3K | 0.04% | 242 |
|
|
2023
Q4 | $532K | Buy |
5,272
+53
| +1% | +$5.12K | 0.05% | 213 |
|
|
2023
Q3 | $532K | Sell |
5,219
-289
| -5% | -$29.3K | 0.06% | 196 |
|
|
2023
Q2 | $556K | Hold |
5,508
| – | – | 0.05% | 202 |
|
|
2023
Q1 | $507K | Buy |
+5,508
| New | +$481K | 0.05% | 229 |
|
|
2020
Q4 | – | Sell |
-1,766
| Closed | -$154K | – | 597 |
|
|
2020
Q3 | $154K | Buy |
+1,766
| New | +$153K | 0.03% | 272 |
|
|
2020
Q1 | – | Sell |
-1,516
| Closed | -$144K | – | 558 |
|
|
2019
Q4 | $144K | Buy |
+1,516
| New | +$136K | 0.02% | 292 |
|
|
2016
Q4 | – | Sell |
-2,924
| Closed | -$207K | – | 268 |
|
|
2016
Q3 | $207K | Sell |
2,924
-2,009
| -41% | -$146K | 0.05% | 215 |
|
|
2016
Q2 | $365K | Hold |
4,933
| – | – | 0.08% | 168 |
|
|
2016
Q1 | $320K | Hold |
4,933
| – | – | 0.07% | 172 |
|
|
2015
Q4 | $380K | Sell |
4,933
-725
| -13% | -$57.6K | 0.09% | 162 |
|
|
2015
Q3 | $466K | Hold |
5,658
| – | – | 0.11% | 148 |
|
|
2015
Q2 | $499K | Hold |
5,658
| – | – | 0.1% | 164 |
|
|
2015
Q1 | $500K | Buy |
5,658
+56
| +1% | +$4.97K | 0.1% | 163 |
|
|
2014
Q4 | $465K | Buy |
5,602
+502
| +10% | +$41.6K | 0.09% | 172 |
|
|
2014
Q3 | $430K | Buy |
5,100
+45
| +0.9% | +$3.64K | 0.1% | 138 |
|
|
2014
Q2 | $410K | Hold |
5,055
| – | – | 0.09% | 147 |
|
|
2014
Q1 | $385K | Hold |
5,055
| – | – | 0.09% | 154 |
|
|
2013
Q4 | $364K | Hold |
5,055
| – | – | 0.09% | 137 |
|
|
2013
Q3 | $347K | Hold |
5,055
| – | – | 0.09% | 129 |
|
|
2013
Q2 | $320K | Buy |
+5,055
| New | +$329K | 0.09% | 133 |
|
Other funds holding NVS
Clear Harbor Asset Management's NVS Position: Q2 2026 in Review
Clear Harbor Asset Management reduced its Novartis (NVS) stake by 2% in Q2 2026, selling an estimated $13.3K and leaving 4,273 shares worth $670K. The position accounts for 0.04% of the portfolio, ranked #277.
Clear Harbor Asset Management first reported a position in NVS in Q2 2013 and has held it in 30 quarters since. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Clear Harbor Asset Management held 4,273 shares of Novartis worth $670K as of Q2 2026.
- Clear Harbor Asset Management sold 89 Novartis shares in Q2 2026, an estimated $13.3K.
- Novartis made up 0.04% of Clear Harbor Asset Management's portfolio in Q2 2026, its #277 holding.
- Clear Harbor Asset Management first reported a position in Novartis in Q2 2013 and has held it in 30 quarters since.
- 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Clear Harbor Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.